downsides of retatrutide Lilly's shows 28% weight loss, but increased side effects Is a new weight-loss drug

Oral Dis2009 Jan;15(1):18-26

Personalized Protocol Dr

TRIUMPH-1 the pivotal general obesity trial with 2,339 patients followed for 80 weeks reported dysesthesia at 12.5% on the 12mg dose, confirming this side effect occurs across different patient populations, not just osteoarthritis patients

3 Takeaways from the Landmark Oral GLP-1 'Switch' Trial for Obesity Care The Weight Maintenance Challenge As clinicians on the front lines of obesity medicine, we are intimately familiar with the central challenge our patients face: sustaining weight loss after a period of initial success

doi: 10.1038/s41594-023-01134-0 28 HeerspinkHJLPerkinsBAFitchettDHHusainMCherneyDZI

Gently blow your nose to clear the nostrils